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Abstract
© 2016, Springer Science+Business Media New York.An increasing number of treatments for
spinal cord injury (SCI) out of the laboratories and in clinical trials pass. Many of them are used
as soon as possible after the injury with the hope of weakening the secondary damage and
maximize the preservation of nerve tissue. The aim of the study was to evaluate the effects
metilprednizalonium and  motor  training  at  an  experimental  spinal  cord  injury  in  rats.  To
investigate the status of the peripheral neuromuscular system registered motor response (M-
response) muscles. In the early period after spinal cord injury was observed, a decrease of the
maximum amplitude of M-response. With that, in the group of animals with the introduction of
metilprednizalonium,  amplitude of  M-response was  higher  than that  without  drug therapy.
Combined therapy metilprednizalonium and motor training has a positive effect on the recovery
of motor function in chronic period after contusion spinal cord injury in rats.
http://dx.doi.org/10.1007/s12668-016-0293-y
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